198 Topics in Current Chemistry Editorial Board: A. de Meijere KN ...
198 Topics in Current Chemistry Editorial Board: A. de Meijere KN ...
198 Topics in Current Chemistry Editorial Board: A. de Meijere KN ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Crystall<strong>in</strong>e Polymorphism of Organic Compounds 177<br />
correlate with higher pack<strong>in</strong>g energy. F<strong>in</strong>ally, from the observation that 24 % of<br />
the polymorphic pairs analysed comprised both a centrosymmetric and a noncentrosymmetric<br />
partner, it was conclu<strong>de</strong>d that the l<strong>in</strong>k between molecular<br />
properties and centrosymmetry of crystals is evi<strong>de</strong>ntly weak. The rea<strong>de</strong>r is<br />
referred to this sem<strong>in</strong>al study [79] for the full exposition of the above conclusions<br />
and their justification, as well as further perceptive observations on the<br />
phenomenon of polymorphism.<br />
3<br />
Methodology for the Study of Crystal Polymorphism<br />
3.1<br />
Review of Preparative Methods<br />
Research on the polymorphism of a new molecular entity normally commences<br />
with experimental screen<strong>in</strong>g which can <strong>in</strong>dicate the occurrence of more than<br />
one crystall<strong>in</strong>e form of the substance. An <strong>in</strong>expensive method of such test<strong>in</strong>g is<br />
hot stage microscopy (HSM), which has been used very extensively and effectively<br />
by a lead<strong>in</strong>g proponent [80] for many years to provi<strong>de</strong> prelim<strong>in</strong>ary <strong>in</strong>dications<br />
of the presence of crystall<strong>in</strong>e polymorphic and pseudopolymorphic<br />
(solvated), as well as glassy (amorphous) forms, all of which may have practical<br />
utility. Pseudopolymorphic forms are molecular adducts conta<strong>in</strong><strong>in</strong>g solvent of<br />
crystallization and have been classified [37] as stoichiometric solvates and nonstoichiometric<br />
<strong>in</strong>clusion compounds possess<strong>in</strong>g channel, layer or cage (clathrate)<br />
structures. Procedures for <strong>de</strong>tect<strong>in</strong>g the existence of multiple forms by HSM<br />
have been outl<strong>in</strong>ed [37, 81]. These <strong>in</strong>clu<strong>de</strong>, for example, the observation of solidsolid<br />
transformation upon heat<strong>in</strong>g the substance,observation of transformation<br />
(spontaneous or mechanically <strong>in</strong>duced) follow<strong>in</strong>g the freez<strong>in</strong>g of a melt, and<br />
<strong>de</strong>tection of gas evolution as bubbles from pseudopolymorphs immersed <strong>in</strong><br />
silicone oil dur<strong>in</strong>g heat<strong>in</strong>g (<strong>in</strong>dicative of a solidÆ gas +solid transformation).<br />
Once the existence of multiple forms is established, practical methods for the<br />
preparation of specific forms on a larger scale may be explored. Frequently,<br />
recrystallization of the compound from solvents or solvent mixtures spann<strong>in</strong>g a<br />
wi<strong>de</strong> polarity range is effective <strong>in</strong> produc<strong>in</strong>g several of the different forms <strong>in</strong> sufficient<br />
quantity for complete characterisation by the analytical methods to be<br />
discussed.Most pseudopolymorphs are prepared by crystallization of the parent<br />
organic compound from the respective solvent, whereupon the latter becomes<br />
<strong>in</strong>corporated <strong>in</strong> the new crystal. Recrystallization from a mixed solvent system<br />
may yield a pseudopolymorph conta<strong>in</strong><strong>in</strong>g either or both solvents. Exposure of<br />
the parent organic compound to vapours may also result <strong>in</strong> the formation of<br />
pseudopolymorphs (as occurs e.g. when anhydrous drugs react with atmospheric<br />
water to form hydrates). This is exemplified by the drug <strong>in</strong>domethac<strong>in</strong>,<br />
for which four polymorphic forms (I–IV) have been i<strong>de</strong>ntified [82]. Crystallization<br />
of the commercially available Form I from over fifty solvents yiel<strong>de</strong>d Forms<br />
I, II, IV and mixtures of these, as well as a number of pseudopolymorphs [83]. To<br />
ensure subsequent reproducibility <strong>in</strong> the preparation of specific forms by<br />
crystallization, careful attention to the <strong>de</strong>tails of solvent purity, <strong>de</strong>gree of solu-